Vascular characterisation of triple negative breast carcinomas using dynamic MRI.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Works by Ah-See, Mei-Lin
Results: 7
1
2
Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 3, p. 193, doi. 10.1007/s00280-023-04554-3
- By:
- Publication type:
- Article
3
Adavosertib (AZD1775) does not prolong the QTc interval in patients with advanced solid tumors: a phase I open-label study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 2, p. 141, doi. 10.1007/s00280-023-04555-2
- By:
- Publication type:
- Article
4
Effect of food on the pharmacokinetics of the WEE1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
5
Management of hot flushes in UK breast cancer patients: clinician and patient perspectives.
- Published in:
- 2017
- By:
- Publication type:
- journal article
6
Assessing response in breast cancer with dynamic contrast-enhanced magnetic resonance imaging: Are signal intensity-time curves adequate?
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 147, n. 2, p. 335, doi. 10.1007/s10549-014-3072-x
- By:
- Publication type:
- Article
7
Inter- and intraobserver variability in the evaluation of dynamic breast cancer MRI.
- Published in:
- Journal of Magnetic Resonance Imaging, 2006, v. 24, n. 6, p. 1316, doi. 10.1002/jmri.20768
- By:
- Publication type:
- Article